Andrea Dessen

Dr. Andrea Dessen


Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 May 1997 in Nature
Verified
Journal Article
Closed access
WWW. Weissenhorn
W. Weissenhorn
ADAndrea Dessen
Andrea Dessen
SHS. C. Harrison
S. C. Harrison
JSJ. J. Skehel
J. J. Skehel
DWD. C. Wiley
D. C. Wiley

1 September 2006 in FEMS Microbiology Reviews
Verified
Journal Article
Closed access
PDF file
PMPauline Macheboeuf
Pauline Macheboeuf
CCCarlos Contreras-Martel
Carlos Contreras-Martel
VJViviana Job
Viviana Job
ODOtto Dideberg
Otto Dideberg
ADAndrea Dessen
Andrea Dessen

17 March 1995 in Science
Verified
Journal Article
Closed access
PDF file
ADAndrea Dessen
Andrea Dessen
AQAnnaïk Quémard
Annaïk Quémard
JBJohn S. Blanchard
John S. Blanchard
WJWilliam R. Jacobs
William R. Jacobs
JSJames C. Sacchettini
James C. Sacchettini
Resistance to isoniazid in Mycobacterium tuberculosis can be mediated by substitution of alanine for serine 94 in the InhA protein, the drug's primary target. InhA was shown to catalyze the β-nicotinamide adenine dinucleotide (NADH)-specific reduction of 2- trans -enoyl-acyl carrier protein, an essential step in fatty acid elongation. Kinetic analyses suggested that isoniazid resistance is due to a decreased affinity of the mutant protein for NADH. The three-dimensional structures of wild-type and mutant InhA, refined to 2.2 and 2.7 angstroms, respectively, revealed that drug resistance is directly related to a perturbation in the hydrogen-bonding network that stabilizes NADH binding.

1 April 1999 in Cell
Verified
Journal Article
Closed access
ADAndrea Dessen
Andrea Dessen
JTJin Tang
Jin Tang
HSHolly Schmidt
Holly Schmidt
MSMark Stahl
Mark Stahl
JCJames D. Clark
James D. Clark
WSWilliam S. Somers
William S. Somers

4 July 1995 in Biochemistry
Verified
Journal Article
Closed access
AQAnnaiek Quemard
Annaiek Quemard
JSJames C. Sacchettini
James C. Sacchettini
ADAndrea Dessen
Andrea Dessen
CVCatherine Vilcheze
Catherine Vilcheze
RBRobert Bittman
Robert Bittman
JBJohn S. Blanchard
John S. Blanchard

1 January 1999 in Molecular Membrane Biology
Verified
Journal Article
Closed access
WWW. Weissenhorn
W. Weissenhorn
ADAndrea Dessen
Andrea Dessen
LCL. J. Calder
L. J. Calder
SHS. C. Harrison
S. C. Harrison
JSJ. J. Skehel
J. J. Skehel
DWD. C. Wiley
D. C. Wiley
Enveloped viruses such as HIV-1, influenza virus, and Ebola virus express a surface glycoprotein that mediates both cell attachment and fusion of viral and cellular membranes. The membrane fusion process leads to the release of viral proteins and the RNA genome into the host cell, initiating an infectious cycle. This review focuses on the HIV-1 gp41 membrane fusion protein and discusses the structural similarities of viral membrane fusion proteins from diverse families such as Retroviridae (HIV-1), Orthomyxoviridae (influenza virus), and Filoviridae (Ebola virus). Their structural organization suggests that they have all evolved to use a similar strategy to promote fusion of viral and cellular membranes. This observation led to the proposal of a general model for viral membrane fusion, which will be discussed in detail.